Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First, is scheduled to end on July 31st. Learn about your options to continue receiving care at Temple Health.
Breadcrumb
- Home
- Clinical Care
- Departments
- Clinical Departments
- Hematology/Oncology
- Immunotherapy
- Checkpoint Inhibitors
Checkpoint Inhibitors
Checkpoint inhibitors enable the body’s own immune system to recognize and destroy cancer cells. Immune system T cells are designed to detect and fight infections and diseases like cancer. They attack when they come across a cancer cell. Tumor cell secrete a substance which inhibits the immune system from attacking it, allowing them to thrive. Checkpoint inhibitors disrupt this process, unleashing the T cells on cancer.
Checkpoint inhibitors are used to treat many different cancers, typically those that have metastasized. Among them are melanoma, non-small cell lung cancer, kidney cancer, bladder cancer, Hodgkin's lymphoma, and some head and neck cancers. Checkpoint inhibitors are sometimes combined to boost their power.
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this